Morita Y, Kojima T, Takeda S, Kinoshita K, Sakamoto S, Baba K, Itoyama S
Department of Obstetrics and Gynecology, Saitama Medical Center.
Nihon Sanka Fujinka Gakkai Zasshi. 1991 Feb;43(2):197-204.
We examined 194 cases of uterine leiomyoma and adenomyosis who received total abdominal hysterectomy, in order to compare the effect of presurgical medical treatment such as with Buserelin, Danazol and Pill, on operative blood loss with non-treated group. The operative blood loss was 314.0 +/- 177.2 ml (mean +/- SD) in the control group (n = 145), 211.2 +/- 64.1 ml in the Buserelin-treated group (n = 26), 276.8 +/- 110.7 ml in the Danazol-treated group (n = 10), and 396.6 +/- 213.1 ml in the Pill-treated group (n = 13). The operative blood loss in the Buserelin-treated group was significantly lower than in the control group (p less than 0.01) and in the Pill-treated group (p less than 0.05). After considering the pathology of the uterus, the uterine size, and the level of expertise of the surgeon, the operative blood loss in the Buserelin-treated group was significantly lower than in the control group. We measured the capillary space, small arteries and veins in the sub-serosal interstitial tissue of the uterus, and observed that the vascular space decreased significantly (p less than 0.01) in the Buserelin-treated group compared to the control group. From these facts it may be concluded that Buserelin presurgical treatment reduces the operative blood loss at hysterectomy, and it seems very likely that the decrease in vascularity may play an important role.
我们检查了194例接受全腹子宫切除术的子宫平滑肌瘤和子宫腺肌病患者,以比较术前使用布舍瑞林、达那唑和避孕药等药物治疗对手术失血的影响与未治疗组的差异。对照组(n = 145)的手术失血量为314.0±177.2 ml(均值±标准差),布舍瑞林治疗组(n = 26)为211.2±64.1 ml,达那唑治疗组(n = 10)为276.8±110.7 ml,避孕药治疗组(n = 13)为396.6±213.1 ml。布舍瑞林治疗组的手术失血量显著低于对照组(p < 0.01)和避孕药治疗组(p < 0.05)。在考虑子宫病理、子宫大小和外科医生的专业水平后,布舍瑞林治疗组的手术失血量仍显著低于对照组。我们测量了子宫浆膜下间质组织中的毛细血管间隙、小动脉和静脉,观察到与对照组相比,布舍瑞林治疗组的血管间隙显著减小(p < 0.01)。从这些事实可以得出结论,术前使用布舍瑞林可减少子宫切除术中的手术失血量,血管减少很可能起到了重要作用。